[1] |
Shi D, Grossman SR. Ubiquitin becomes ubiquitous in cancer emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets[J]. Cancer Biol Ther,2010,10(8): 737-47.
|
[2] |
Gousseva N, Baker RT. Gene structure, alternate splicing, tissue distribution, cellular localization, and developmental expression pattern of mouse deubiquitinating enzyme isoforms Usp2-45 and Usp2-69[J]. Gene Expr,2003,11(3-4):163-79.
|
[3] |
Mahul-Mellier AL, Datler C, Pazarentzos E,et al. De-ubiquitinating proteases USP2a and USP2c cause apoptosis by stabilising RIP1[J]. Biochim Biophys Acta,2012,1823(8):1353-65.
|
[4] |
Metzig M, Nickles D, Falschlehner C, et al. An RNAi screen identifies USP2 as a factor required for TNF-α-induced NF-κB signaling[J]. Int J Cancer, 2011,129(3):607-18.
|
[5] |
Stevenson LF, Sparks A, Allende-Vega N, et al. The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2[J]. EMBO J,2007,26(4):976-86.
|
[6] |
Oishi K, Miyazaki K, Kadota K, et al. Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes[J]. J Biol Chem, 2003, 278(42):41519-27.
|
[7] |
Lin H, Yin L, Reid J,et al. Divergent N-terminal sequences of a deubiquitinating enzyme modulate substrate specifi city[J]. J Biol Chem,2001,276(23): 20357-63.
|
[8] |
Priolo C, Tang D, Brahamandan M, et al. The isopeptidase USP2a protects human prostate cancer from apoptosis[J]. Cancer Res, 20 06, 66(17): 8625-32.
|
[9] |
Ye SW,Wang MW,Chen QR,et al.Expression of USP2 and CyclinD1 in Gastric Carcinoma and Its Clinicopathologic Singnificance[J].Zhongguo Zhong Liu,2014,23(4):257-60.[叶盛 威,王明伟,陈琼荣,等.Usp2和CyclinD1蛋白在胃癌中的表达及 其临床意义[J].中国肿瘤,2014,23(3):257-60.]
|
[10] |
Graner E, Tang D, Rossi S, et al. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer[J]. Cancer Cell, 2004, 5(3):253-61.
|
[11] |
Shan J, Zhao W, Gu W. Suppression of cancer cell growth by promoting cyclin D1 degradation[J]. Mol Cell, 2009, 36(3): 469- 76.
|
[12] |
Kim J, Kim WJ, Liu Z, et al. The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer[J]. Cell Cycle, 2012, 11(6): 1123-30.
|
[13] |
Nadler Y, Camp RL, Schwartz C, et al. Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer[J]. Clin Cancer Res, 2008, 14(14): 4455-62.
|
[14] |
Shi Y, Solomon LR, Pereda-Lopez A,et al. Ubiquitin-specific cysteine protease 2a (USP2a) regulates the stability of Aurora- A[J] J Biol Chem, 2011, 286(45): 38960-8.
|
[15] |
Allende-Vega N, Sparks A, Lane DP, et al. MdmX is a substrate for the deubiquitinating enzyme USP2a[J]. Oncogene, 2010, 29 (3):432-41.
|
[16] |
Gewies A,Grimm S. UBP41 is a proapoptotic ubiquitin-specific protease[J]. Cancer Res, 2003, 63(3): 682-8.
|
[17] |
Haimerl F, Erhardt A, Sass G, et al. Down-regulation of the deubiquitinating enzyme ubiquitin-specifi c protease 2 contributes to tumor necrosis factor-alpha-induced hepatocyte survival[J]. J Biol Chem, 2009, 284(1): 495-504.
|